TCL Archive FDA Advisors Okay NCI Toxicology Proposals, Write New Clinical Guidelines, Approve AIN DA October 19, 1979
TCL Archive In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads August 8, 1980
TCL Archive Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks July 25, 2014
